Last Updated: 31-07-2025 | Format: PDF | Report ID:20379 | Author: Alice
| Key Market Question | Answer |
|---|---|
| What is the market size in 2025? | $1,350 Million |
| What is the projected market size by 2035? | $3,540 Million |
| What is the market CAGR from 2025 to 2035? | 10.1% |
| Which region dominates the market? | US (72%) |
| Which product/service type dominates the market? | mRNA Sequencing (38%) |
| Which application leads the market? | Diagnostics (41%) |
| Who are the major buyers? | Academic/Research (46%), Clinical Laboratories (32%) |
| What are the key market growth drivers? | Rising demand for precision and personalized medicine is accelerating the adoption of NGS-based RNA-sequencing; Significant reduction in sequencing costs and increased throughput |
| What are the major market challenges? | Data management and storage complexities due to the massive volume of datasets generated by next-generation RNA-sequencing remain a significant challenge; Standardization of protocols and bioinformatic pipelines remains inconsistent across research and clinical labs |
| What is the forecast period? |
Study period:
2020-2035
Base year:
2026
Historical data
2020-2024
NO OF PAGE:
167
What You Get:
| 2026–2035 |
| Who are the key market players? | Illumina Inc., Thermo Fisher Scientific, Agilent Technologies, QIAGEN, BGI, PerkinElmer Inc., Pacific Biosciences, F. Hoffmann-La Roche AG, Lexogen GmbH, Takara Bio Inc., Oxford Nanopore Technologies, Arraystar Inc., NuGEN Technologies (TECAN Group), Eurofins Scientific, Macrogen Inc. |
Europe Early Stage Cancer Market: by Type (Biomarker-based Screening, Imaging-based Screening, Liquid Biopsy, Molecular Diagnostics, Immunoassay, Others), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Others), Distribution Channels (Hospitals, Diagnostic Centers, Cancer Research Institutes, Specialty Clinics, Ambulatory Surgical Centers, Others), Technology (PCR, Next-Generation Sequencing, Immunohistochemistry, In Situ Hybridization, Flow Cytometry, Others), Organization Size (Small, Medium, Large) and By Europe Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Human Identification Market Market: by Type (DNA Analysis, Biometric Analysis, Facial Recognition, Fingerprint Analysis, Iris Recognition, Voice Recognition) Application (Forensic Applications, Paternity Testing, Disaster Victim Identification, Population Genetics, Wildlife Forensics, Others), Distribution Channels (Online, Offline, Direct Sales, Distributors, Resellers, Others), Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Capillary Electrophoresis, Automated Fingerprint Identification, Digital Imaging, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America HLA Typing Market Market: by Type (Molecular Assays, Non-Molecular Assays), Application (Transplantation, Research, Disease Diagnosis, Donor Screening, Drug Discovery, Others), Distribution Channels (Direct Tenders, Retail Sales, Online Sales, Distributors & Wholesalers, Hospital Pharmacies, Others), Technology (PCR-Based Molecular Assays, Sequencing-Based Molecular Assays, SSO-PCR, SSP-PCR, Non-Molecular Assays, Other Technologies), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Oligonucleotide CDMO Market: by Type (Custom Oligonucleotides, Pre-designed Oligonucleotides, DNA Oligonucleotides, RNA Oligonucleotides, Modified Oligonucleotides, Others), Application (Diagnostics, Research, Therapeutics, Forensics, Others), Distribution Channels (Direct Tender, Online Sales, Distributors, Retail Sales, Others), Technology (Solid-Phase Synthesis, Liquid-Phase Synthesis, Enzymatic Synthesis, PCR-based Synthesis, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025
North America Gene Expression Analysis Market: by Type (Consumables, Instruments, Software, Services), Application (Drug Discovery, Diagnostics, Research, Personalized Medicine, Agriculture, Others), Distribution Channels (Direct Sales, Distributors, Online, Retail, Others), Technology (PCR, Microarray, NGS, Sanger Sequencing, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025